Longevity Technology: ‘Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19’

Relation Therapeutics, Inc., a Juvenescence partner, and Mila, the Montreal-based AI research institute announced that they are collaborating on a new project targeting the development of COVID-19 therapeutics. Funded by the Bill & Melinda Gates Foundation to the tune of $1.3m, Project RE aims to leverage the most powerful machine learning techniques to find therapies to tackle viral entry and replication.

Relation’s Chief Medical Officer, Dr. David Roblin, who is overseeing the creation of the platform this project aims to create, said: “Our race together is to beat COVID-19 and improve patient outcomes by identifying existing therapeutics that can be repurposed. To do this we have assembled an outstanding team with Mila and Relation data science, machine learning, biology and drug development expertise. This is essential funding to enable these efforts.”

Read the full article at Longevity Technology.